Cargando…
Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine
Migraine is a common neurovascular disorder, affecting millions of people worldwide. Current guidelines recommend triptans as first-line treatment for moderate-to-severe migraine attacks. Frovatriptan is a second-generation triptan with a longer terminal elimination half-life in blood than other tri...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055118/ https://www.ncbi.nlm.nih.gov/pubmed/27757013 http://dx.doi.org/10.2147/DDDT.S105932 |